Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Merit Medical Systems ( (MMSI) ) has issued an update.
On February 24, 2026, Merit Medical reported its fourth-quarter and full-year 2025 results, highlighting double‑digit revenue growth and expanding margins. For the quarter, revenue rose 11% to $393.9 million, GAAP operating margin improved to 13.8%, non‑GAAP operating margin reached 21.0%, GAAP EPS climbed 37% to $0.63, non‑GAAP EPS increased 12% to $1.04, and free cash flow grew 13% to $74 million.
For fiscal 2025, revenue increased 12% to $1.516 billion, with constant‑currency organic growth of 7%, GAAP operating margin advancing to 12.2%, non‑GAAP operating margin to 20.3%, GAAP EPS rising 5% to $2.13, non‑GAAP EPS up 11% to $3.83 and free cash flow up 16% to $215.7 million. Management issued 2026 guidance calling for 6%–8% reported revenue growth to as much as $1.63 billion and a further 5%–8% increase in non‑GAAP EPS, underscoring confidence in continued margin expansion and the final‑year targets of its Continued Growth Initiatives Program through 2026.
The most recent analyst rating on (MMSI) stock is a Buy with a $106.00 price target. To see the full list of analyst forecasts on Merit Medical Systems stock, see the MMSI Stock Forecast page.
Spark’s Take on MMSI Stock
According to Spark, TipRanks’ AI Analyst, MMSI is a Outperform.
The score is driven primarily by strong financial performance—especially cash flow quality and a stable balance sheet—plus supportive price momentum and an upbeat earnings outlook with raised/affirmed growth and free-cash-flow expectations. The main offset is valuation, as the high P/E meaningfully reduces the overall score.
To see Spark’s full report on MMSI stock, click here.
More about Merit Medical Systems
Merit Medical Systems, Inc., based in South Jordan, Utah, is a leading global manufacturer and marketer of healthcare technology, with a portfolio focused on cardiovascular and endoscopy devices, custom procedural solutions and OEM products. The company targets hospital and clinic-based interventional procedures worldwide and is listed on the NASDAQ under the ticker MMSI.
Average Trading Volume: 664,213
Technical Sentiment Signal: Hold
Current Market Cap: $4.92B
For a thorough assessment of MMSI stock, go to TipRanks’ Stock Analysis page.